Literature DB >> 7826573

Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.

W F Gattaz1, B Schummer, S Behrens.   

Abstract

In the present study we compared the effects of the atypical neuroleptic zotepine to haloperidol and clozapine on stereotypies and locomotion induced in rats by the N-methyl-D-aspartate (NMDA) antagonist MK-801. Zotepine caused a dose-dependent reduction of MK-801-induced stereotypies and locomotion. Zotepine at a dosis of 2.5 mg/kg body weight showed a similar effect to 0.25 mg/kg haloperidol in reducing stereotypies and locomotion. Clozapine (5.0 mg/kg) reduced significantly locomotion and non-significantly stereotypies. These results add support to the assumption that MK-801-induced behavior provides an adequate animal model to test the potential efficacy of typical and atypical neuroleptics in the treatment of psychoses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826573     DOI: 10.1007/bf01294789

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  17 in total

1.  Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.

Authors:  D C Hoffman
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 2.  Basic biology of clozapine: electrophysiological and neuroendocrinological studies.

Authors:  G A Gudelsky; J F Nash; S A Berry; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Neuropharmacology of zotepine, an antimanic drug: a potent blocker of D2 and 5-HT2 receptors of human brain.

Authors:  S Kanba; G Yagi; E Oguchi; T Nakaki; R Kato; E Richelson
Journal:  Jpn J Psychiatry Neurol       Date:  1991-03

4.  [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].

Authors:  E Klieser; E Lehmann; J Tegeler
Journal:  Fortschr Neurol Psychiatr       Date:  1991-09       Impact factor: 0.752

5.  [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].

Authors:  W W Fleischhacker; C Barnas; C H Stuppäck; B Sperner-Unterweger; C Miller; H Hinterhuber
Journal:  Fortschr Neurol Psychiatr       Date:  1991-09       Impact factor: 0.752

6.  Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats.

Authors:  A Ouagazzal; A Nieoullon; M Amalric
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Phencyclidine-induced psychosis.

Authors:  R M Allen; S J Young
Journal:  Am J Psychiatry       Date:  1978-09       Impact factor: 18.112

8.  Profiles of clinical efficacy and pharmacological action of zotepine.

Authors:  S Yamawaki
Journal:  Pharmacopsychiatry       Date:  1987-02       Impact factor: 5.788

9.  Possible relationship between antimanic effect and activity of zotepine to 5HT1 receptor.

Authors:  T Harada; T Ebara; S Otsuki
Journal:  Folia Psychiatr Neurol Jpn       Date:  1984

10.  MK-801-induced stereotypy and its antagonism by neuroleptic drugs.

Authors:  P I Tiedtke; C Bischoff; W J Schmidt
Journal:  J Neural Transm Gen Sect       Date:  1990
View more
  8 in total

Review 1.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Selective blockade of N-methyl-D-aspartate channels in combination with dopamine receptor antagonism induces loss of the righting reflex in mice, but not immobility.

Authors:  Nobuhito Kikuchi; Masahiro Irifune; Yoshitaka Shimizu; Keita Yoshida; Katsuya Morita; Takashi Kanematsu; Norimitsu Morioka; Yoshihiro Nakata; Norio Sakai
Journal:  Psychopharmacology (Berl)       Date:  2014-05-31       Impact factor: 4.530

3.  Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.

Authors:  Laura Albizu; Terrell Holloway; Javier González-Maeso; Stuart C Sealfon
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

Review 4.  Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.

Authors:  Bita Moghaddam; John H Krystal
Journal:  Schizophr Bull       Date:  2012-08-16       Impact factor: 9.306

5.  Animal Models of Psychosis: Current State and Future Directions.

Authors:  Alexandra D Forrest; Carlos A Coto; Steven J Siegel
Journal:  Curr Behav Neurosci Rep       Date:  2014-06-01

6.  Acute N-methyl-D-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats.

Authors:  I Feinstein; M F Kritzer
Journal:  Neuroscience       Date:  2012-10-22       Impact factor: 3.590

7.  Inducible Nitric Oxide Inhibitors Block NMDA Antagonist-Stimulated Motoric Behaviors and Medial Prefrontal Cortical Glutamate Efflux.

Authors:  Hadley C Bergstrom; Altaf S Darvesh; S P Berger
Journal:  Front Pharmacol       Date:  2015-12-15       Impact factor: 5.810

8.  Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM-042 [(E)-4-(2-(2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)vinyl)-6-(pyrrolidin-1-yl)pyrimidin-4-yl)morpholine] in rats: potential for the treatment of schizophrenia.

Authors:  Keita Arakawa; Shunsuke Maehara; Natsuko Yuge; Makoto Ishikawa; Yutaka Miyazaki; Hiroyasu Naba; Yutaka Kato; Kazunari Nakao
Journal:  Pharmacol Res Perspect       Date:  2016-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.